A new study has discovered that a type of bacteria commonly found in the body, which usually does not pose problems for healthy people, plays a significant role in causing stomach cancer, the fifth most common cancer in the ...
Mar 18, 2024
0
32
Researchers at the Duke-NUS Graduate Medical School in Singapore have identified numerous new subtypes of gastric cancer that are triggered by environmental factors.
Oct 17, 2012
0
0
New trial data showing improvements in the treatment of esophageal and gastrointestinal cancers were released today at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.
Sep 29, 2012
0
0
Helicobacter pylori infects approximately half of the world's population and is the strongest known risk factor for developing gastric cancer. Gastric cancer is the third most lethal cancer worldwide.
Oct 4, 2019
0
6
Stomach cancer, or gastric cancer, is a common gastrointestinal malignancy. Peritoneal metastasis occurs in a majority of patients with advanced stomach cancer and is considered as an aggressive disease with poor outcomes.
Jan 7, 2021
0
4
Stomach cancer, one of the leading causes of cancer death worldwide, actually falls into three broad subtypes that respond differently to currently available therapies, according to researchers at Duke-NUS Graduate Medical ...
Aug 27, 2013
0
0
(HealthDay)—Long-term proton pump inhibitor (PPI) use is associated with increased risk of fundic gland polyps (FGPs), and may be associated with gastric cancer, according to a review published in the December issue of ...
Nov 24, 2016
0
1
A team of scientists from the Cancer Science Institute of Singapore (CSI Singapore) at the National University of Singapore (NUS) discovered that a protein named IL23A is part of our stomach's defence against bacterial infection ...
Jul 4, 2014
0
0
A new review published in the Cochrane Library indicates that eradicating Helicobacter pylori bacterium— the main cause of stomach ulcers - with a short course of therapy comprising two commonly used medicines may help ...
Jul 22, 2015
0
18
An international phase 3 clinical trial, done in participation with Weill Cornell Medicine and NewYork-Presbyterian, has found that a new targeted treatment called zolbetuximab, given in combination with a standard chemotherapy, ...
Aug 23, 2023
0
44
